FERRING PHARMACEUTICALS A/S: Financial statements 2025
CVR: 16313440
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
FERRING PHARMACEUTICALS A/S (CVR 16313440) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. That is an increase of 2.4% compared with the year before. The profit margin was 2.8%. Equity in the 2025 report amounted to DKK 315,220,000. The solvency ratio was 47%. The company had 577 employees in the financial year.
- Revenue
- DKK 1,730,413,000
- Gross Profit
- DKK 824,399,000
- Profit/Loss
- DKK 49,005,000
- Equity
- DKK 315,220,000
- Total Assets
- DKK 671,064,000
- Employees
- 577
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1.7B | 824.4M | 49M | 315.2M | 577 |
| 2024 | 1.7B | 811.1M | 76.9M | 266.2M | 487 |
| 2023 | 1.5B | 707.8M | 67.1M | 189.3M | 497 |
| 2022 | 1.3B | 645.9M | 52.4M | 122M | 559 |
| 2021 | 1B | 1B | 40.2M | 69.6M | 487 |
Official annual report
How creditworthy is FERRING PHARMACEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 24, 2025, Tamara Vukmirovic is registered as director of FERRING PHARMACEUTICALS A/S.
As of September 15, 2025, Jesper Thomsen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 15, 2025, Jesper Thomsen has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 15, 2025, Jesper Thomsen is registered as director of FERRING PHARMACEUTICALS A/S.
As of July 21, 2025, Anette Hedegaard Østergaard has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of July 21, 2025, Klaus Grønbæk Jakobsen has stepped down as director of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2024. Revenue came to DKK 1,690,294,000, and the net result was DKK 76,890,000.
About FERRING PHARMACEUTICALS A/S
FERRING PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named FERRING NORDIC PHARMACEUTICALS A/S and A/S PSE 38 NR. 1587. The management consists of Jan Peutzfeldt, Ingbritt Tolstrup Birk and Jesper Thomsen. The board consists of Marianne Kock (chair), Dag Frederik Arfst Paulsen and Jean-Frederic Paulsen. The company is owned by Ferring B.V.. The company has 522 employees (2026). In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. Equity in the 2025 report amounted to DKK 315,220,000.